Chai infuses AI drug discovery efforts with $130M series B
Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to further energize development of its “computer-aided design…
Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to further energize development of its “computer-aided design…